纯度 | >90%SDS-PAGE. |
种属 | Human |
靶点 | MAP1LC3B |
Uniprot No | Q9GZQ8 |
内毒素 | < 0.01EU/μg |
表达宿主 | E.coli |
表达区间 | 1-120aa |
氨基酸序列 | MPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETFG |
预测分子量 | 18.2 kDa |
蛋白标签 | His tag N-Terminus |
缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
nan
MAP1LC3B (microtubule-associated protein 1 light chain 3 beta), also known as LC3B, is a critical autophagy-related protein involved in the formation and maturation of autophagosomes. It is a mammalian homolog of yeast Atg8 and serves as a widely used marker for monitoring autophagy. The native LC3B protein exists in two forms: a cytosolic pro-form (proLC3) that is processed into LC3-I, which is subsequently conjugated to phosphatidylethanolamine (PE) to form LC3-II. LC3-II localizes to autophagosomal membranes, playing essential roles in cargo recognition, membrane expansion, and autophagosome-lysosome fusion.
Recombinant MAP1LC3B protein is produced through genetic engineering techniques, typically expressed in bacterial or mammalian systems. Its purified form retains functional properties, enabling in vitro studies on autophagy mechanisms, protein-protein interactions, and drug screening. Researchers often utilize fluorescently tagged LC3B (e.g., GFP-LC3B) to visualize autophagosome dynamics in live-cell imaging.
This recombinant protein has become indispensable in autophagy research due to its ability to quantify autophagic flux when combined with lysosomal inhibitors. It also facilitates studies linking autophagy to various pathologies, including neurodegenerative diseases, cancer, and infectious diseases. Pharmaceutical applications include screening autophagy-modulating compounds and validating therapeutic targets. Compared to other LC3 isoforms, LC3B shows higher specificity in autophagosome association, making it a preferred choice for experimental models. Its recombinant version maintains consistent activity across applications while avoiding contamination risks associated with native protein purification.
×